What are the recommended dosing, contraindications, and adverse effects of sulindac?

Sulindac: Dosing, Contraindications, and Adverse Effects

Sulindac is dosed at 150-200 mg twice daily for most inflammatory conditions, with a maximum of 400 mg daily, but should be avoided in patients with cirrhosis or significant renal impairment due to its notably higher hepatotoxicity compared to other NSAIDs. 1, 2

Recommended Dosing

Standard dosing varies by indication:

• Osteoarthritis/Rheumatoid Arthritis: 150 mg twice daily, may increase to 200 mg twice daily (total 300-400 mg/day) 2
• Ankylosing Spondylitis: 200-400 mg daily 2
• Acute Painful Shoulder: 300-400 mg daily 2
• Acute Gout: 400 mg daily initially 2

The medication is taken twice daily and typically shows effectiveness within 24 hours. 3 Generic cost is approximately $19-28 per month for standard doses. 1

Critical dosing adjustments:

• Hepatic impairment: Reduce dose significantly; plasma concentrations of active metabolite are higher in alcoholic liver disease 2
• Renal impairment: Lower daily dosage required; sulindac is eliminated primarily by kidneys and accumulates in renal dysfunction 2
• Elderly: May require dose reduction due to accumulation with long-term use 4

Absolute Contraindications

Do not prescribe sulindac in these situations: 2

1. Known hypersensitivity to sulindac
2. History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs (risk of severe anaphylactic/anaphylactoid reactions)
3. Peri-operative CABG surgery

Major Adverse Effects and Precautions

Hepatotoxicity (Most Critical for Sulindac)

Sulindac carries distinctly higher hepatic risk than other NSAIDs and should be specifically avoided in cirrhosis. 1 While clinically significant hepatotoxicity is rare in the general population, sulindac and diclofenac show higher rates of hepatic injury and transaminase elevation >3x upper limit of normal compared to other NSAIDs. 1 Serious multi-organ toxicity including hepatic involvement has been reported, including fatal cases. 5

Gastrointestinal Effects

• Dyspepsia/abdominal pain: 10-20% prevalence 1
• GI bleeding risk: Age-dependent (1 in 2,100 for age <45; 1 in 110 for age >75 annually) 1
• Higher GI toxicity: Sulindac has prominent enterohepatic circulation and prolonged half-life, linked to greater GI toxicity than ibuprofen, etodolac, or nabumetone 6

Mitigation strategies:

• Combine with PPI or H2 blocker for dyspepsia
• Avoid in patients with history of NSAID-associated upper GI bleeding
• If GI protection needed, use PPI or misoprostol 1

Cardiovascular Complications

• Mean blood pressure increase of 5 mm Hg 1
• Avoid in congestive heart failure (all NSAIDs worsen CHF)
• Use with caution in hypertension
• Increased risk of myocardial infarction and ischemia 1

Renal Complications

All NSAIDs cause volume-dependent renal failure; 2% of patients discontinue NSAIDs due to renal complications. 1 Sulindac is eliminated primarily by kidneys, requiring close monitoring in renal impairment. 2

High-risk scenarios requiring avoidance or extreme caution:

• Pre-existing renal disease
• Congestive heart failure
• Cirrhosis
• Concurrent use with ACE inhibitors, ARBs, or beta blockers (increases renal complication risk) 1

Hematologic Effects

• Antiplatelet effects: Avoid in platelet defects or thrombocytopenia 1
• Drug interactions: GI bleeding risk increases 3-6 fold when combined with anticoagulants; INR increases up to 15% 1
• Perioperative management: Stop sulindac for five elimination half-lives before surgery 1

Other Notable Adverse Effects

• Constipation: Occurs in 20-30% of patients, usually mild 3
• Aspirin-exacerbated respiratory disease: Use with caution in asthma, especially with nasal polyps 1
• Pregnancy: Avoid 6-8 weeks before term (prolonged labor, fetal antiplatelet effects) 1

Common Pitfalls to Avoid

1. Do not use sulindac as first-line NSAID in patients with any liver disease—choose ibuprofen or naproxen instead 1
2. Do not combine with anticoagulants without PPI prophylaxis and expect INR changes 1
3. Do not prescribe in elderly without considering dose reduction—accumulation occurs with chronic use 4
4. Monitor renal function in high-risk patients, though optimal monitoring frequency remains unclear 1
5. Higher doses (600 mg daily) increase adverse effects without improving efficacy 7